Alcon (ALC) EV to CFO (2019 - 2026)
Alcon (ALC) posted EV to CFO of 61.28 for Q2 2026, down 26.96% on a QoQ basis from 83.9 in Q1 2026, and down 26.8% year-over-year from 83.72 in Q2 2025.
Analysis
Alcon (ALC) EV to CFO (2019 - 2026) Analysis & Trends
Alcon has reported EV to CFO for 8 years, with the latest figure at 61.28 in Q2 2026.
- On a quarterly basis, EV to CFO fell 26.8% year-over-year to 61.28 in Q2 2026; TTM through Jun 2026 was 13.53, a 28.29% decrease from a year earlier, with the FY2025 full-year figure at 16.21, down 16.17% from the prior year.
- EV to CFO was 61.28 for Q2 2026 at Alcon, down from 83.9 in the prior quarter.
- The five-year high for EV to CFO was 571.16 in Q1 2022, with the low at 47.81 in Q3 2025.
- Average EV to CFO over 5 years is 126.87, with a median of 83.01 recorded in 2023.
- The sharpest annual moves came in 2022 and 2024: EV to CFO surged 173.71% in 2022, then plunged 70.6% in 2024.
- Over 5 years, EV to CFO stood at 93.71 in 2022, then declined by 11.41% to 83.01 in 2023, then advanced by 5.4% to 87.49 in 2024, then sank by 36.06% to 55.94 in 2025, then increased by 9.54% to 61.28 in 2026.
- The last three EV to CFO figures came in at 61.28 (Q2 2026), 83.9 (Q1 2026), and 55.94 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn |
| 10 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 61.28 |
| Mar 31, 2026 | 83.90 |
| Dec 31, 2025 | 55.94 |
| Sep 30, 2025 | 47.81 |
| Jun 30, 2025 | 83.72 |
| Dec 31, 2024 | 87.49 |
| Sep 30, 2024 | 63.78 |
| Jun 30, 2024 | 79.17 |
| Mar 31, 2024 | 115.40 |
| Dec 31, 2023 | 83.01 |
| Sep 30, 2023 | 68.69 |
| Jun 30, 2023 | 120.21 |
| Mar 31, 2023 | 392.59 |
| Dec 31, 2022 | 93.71 |
| Sep 30, 2022 | 67.35 |
| Jun 30, 2022 | 81.62 |
| Mar 31, 2022 | 571.16 |
| Dec 31, 2021 | 105.70 |
| Sep 30, 2021 | 90.35 |
| Jun 30, 2021 | 84.94 |